Continuously provide innovative solutions to clinical and health difficulties or pain points
MoreContinuously provide innovative solutions to clinical and health difficulties or pain points
Continuously provide innovative solutions to clinical and health difficulties or pain points
MoreProduct development for early detection and detection in the fields of cancer, neurodegenerative diseases, and infectious diseases
MoreFocus on the creation of immune and molecular POCT production lines
MoreProfessor Zhang Mingdong leads the overseas technical team
MoreSelf-developed ctDNA liquid biopsy and unique tumor marker detection reagents and other tumor prevention and rehabilitation detection technologies are the core
A "refined" tool for postoperative follow-up management/self-management of bowel cancer patients
Can carry out common medical laboratory subjects including clinical cytomolecular genetics, clinical immunity, serological testing and other majors, mainly engaged in tumor genetic testing, testing services related to major infectious diseases
4月22日下午,國家商務部外貿司劉長于巡視員一行蒞臨上海良潤生物醫藥科技有限公司開展關于醫療物資出口的調查研究,此次調研旨在了解企業醫療物資生產及出口基本情況、企業醫療物資質量管控的工作情況,以及存在的問題和
根據上海市委書記李強11月17日在浦東調研專題座談會的指示精神,按照祖亮書記的指示要求,為謀劃推動長三角自貿試驗區聯動發展,上海浦東新區楊朝副區長于12月23日上午在浦東新區管委會主持召開了長三角自貿試驗區企業座談
著國家對“精準醫療”戰略規劃的啟動,基于大數據的精準分析,運用分子診斷的技術的個體化的篩查路徑成為戰略發展的方向和重中之重。
To Provide Innovative Solutions for
the Diagnosis of Critical Diseases
Seeking Truth from Facts
Pioneering on Our Innovation
To Be a Leading IVD Enterprise Driven by Liquid
Biopsy Technologies and Targeting International Markets
Simplicity Integrity Excellence